Regulatory actions for Sept. 20-26, 2022
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Amniotics, Antengene, Astrazeneca, Bausch Lomb, Beigene, Biontech, Frontera, Glenmark, Junshi, Keymed, Merck, Pfizer, Veru.
Regulatory actions for Sept. 20-26, 2022
Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Amniotics, Antengene, Astrazeneca, Bausch Lomb, Beigene, Biontech, Frontera, Glenmark, Junshi, Keymed, Merck, Pfizer, Veru.